Ownership history in Logos Global Management LP · 22 quarters on record
This page tracks every 13F SEC filing in which Logos Global Management LP reported a position in DYNE THERAPEUTICS INC (DYN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,250,000 | -1,150,000 | -47.9% | 1.48% | $24.4M | $19.56 |
| 2025 Q3 | ADDED | 2,400,000 | +500,000 | +26.3% | 2.72% | $30.4M | $12.65 |
| 2025 Q2 | ADDED | 1,900,000 | +1,400,000 | +280.0% | 2.00% | $18.1M | $9.52 |
| 2025 Q1 | ADDED | 500,000 | +50,000 | +11.1% | 0.93% | $5.2M | $10.46 |
| 2024 Q4 | ADDED | 450,000 | +290,000 | +181.2% | 1.24% | $10.6M | $23.56 |
| 2024 Q3 | REDUCED | 160,000 | -105,000 | -39.6% | 0.62% | $5.7M | $35.92 |
| 2024 Q2 | REDUCED | 265,000 | -1,465,000 | -84.7% | 0.76% | $9.4M | $35.29 |
| 2024 Q1 | REDUCED | 1,730,000 | -150,000 | -8.0% | 3.98% | $49.1M | $28.39 |
| 2023 Q4 | REDUCED | 1,880,000 | -300,000 | -13.8% | 2.33% | $25.0M | $13.30 |
| 2023 Q3 | ADDED | 2,180,000 | +400,000 | +22.5% | 2.61% | $19.5M | $8.96 |
As of 2025 Q4 — sorted by position size